Linda Crnic Institute for Down Syndrome
The leader in scientific research benefiting people with Down syndrome
Meet the Crnic Institute Supergroup 2017 Grant Recipients
|
Brianne Bettcher, PhD
Alzheimer’s and Down syndrome
Investigate the correlation between biomarkers of inflammation, brain structure, and neuropsychological functioning
|
Ganna Bilousova, PhD
Stem cells and Down syndrome
Exploring Endothelial Progenitor Cell Defects in Down Syndrome
|
Zhe Chen, PhD
Neurology & Down syndrome
Study how an extra copy of chromosome 21 affects axon guidance in the brain
|
Angelo D’Alessandro
Proteomics of Down syndrome
Metabolic Alterations of Trisome 21
|
James DeGregori, PhD
Leukemia & Down syndrome
Study increase in leukemia incidence and other problems with blood cell production, including reduced immunity
|
Mark Dell’Acqua, PhD
Alzheimer’s disease & Down syndrome
Study the role of calcium signaling in inhibition of synapse formation by A-beta plaque in Down syndrome
|
Robin Dowell, PhD
Genetic understanding of Down syndrome
Understand how an extra copy of chromosome 21 affects the behavior of key proteins involved in regulating expression
|
Joaquín Espinosa, PhD
Genetic understanding of Down syndrome
Identify genes whose function is essential in trisomic cells yet dispensable in cells with only two copies of chromosome 21
|
Santos Franco, PhD
Neurons in brains of Down syndrome mice
Defects in Neurogenesis and Neuronal Migration in DS Mouse Models: Elucidating the Developmental and Molecular Mechanisms
|
Csaba Galambos, MD, PhD
Lung development in Down syndrome
Overexpression of anti-angiogenic genes impairs lung development in Dp16 mice
|
Francis J. Hickey, MD
Anesthesia & Down syndrome
Provide information to improve management of post-operative pain and sedation in children with Down syndrome
|
Charles A. Hoeffer, PhD
Alzheimer’s disease & Down syndrome
Test the idea that overexpression of a key gene on chromosome 21 promotes the development of Alzheimer’s disease-related neuropathology
|
Elena Hsieh, MD
Interferon response in Down syndrome blood cells
Understanding the Hyperactive Interferon Response in Trisomy 21 at the Single-Cell Level
|
Aaron Johnson, PhD
Genetic understanding of Down syndrome
Reconstitute chromosome 21 in the test tube to understand how it can be turned off by an RNA molecule
|
Kevin Jones, PhD
Gene regulation & Down syndrome
Test whether increasing the abundance of the BDNF protein can prevent Down syndrome pathology in a mouse model
|
Matthew Kennedy, PhD
Alzheimer’s disease & Down syndrome
Investigate how increased beta-amyloid production causes synapse loss in hope of finding targets for future therapies
|
Michael Klymkowsky, PhD
Neurodevelopment in Down syndrome
Inductive signaling in human iPSC-derived euploid and trisomic 21 cerebral organoids
|
Laurel Lenz, PhD
Interferon response in Down syndrome blood cells
Mechanisms responsible for increased type I IFN responses in Trisomy 21
|
Christopher Link, PhD
Genetic understanding of Down syndrome
Determine which genes have altered expression due to Trisomy 21
|
Changwei Liu, PhD
Protein expression & Down syndrome
Study the effect of USP16 overexpression on a large number of other cellular proteins to determine whether USP16 may be key to many phenotypes
|
Ken Maclean, PhD
Cognition & Down syndrome
Test a highly specific inhibitor of a key protein active in the Unfolded Protein Response as a potential therapeutic target for cognitive deficits
|
Steven Maier, PhD
Cognition & Down syndrome
Understand the contribution of inflammation in the brain to cognitive deficits of Down syndrome
|
Niklaus Mueller, PhD
Changes in the eye lens in Down syndrome
Malformation of the Ocular Lens in Down Syndrome Visual Impairment
|
Brian O’Connor, PhD
Chromosomal changes in Down syndrome cells
Examining Chromatin Regulation of Adaptive Immune Dysfunction in Down Syndrome
|
William Old, PhD
Protein expression & Down syndrome
Study genes with altered protein expression to develop new therapeutic strategies to alleviate issues with neurodevelopment and neurodegenerative pathologies
|
Bradley Olwin, PhD
Muscle development & Down syndrome
Test the idea that muscle weakness in Down syndrome is due to failure of muscle stem cells to function properly
|
Chad Pearson, PhD
Cell signaling in Down syndrome
A new ciliary basis for understanding Down
syndrome phenotypes
|
Anne-Laure Perraud, PhD
Immune dysfunction & Down syndrome
Determine the role of a chromosome 21 protein that forms an ion channel in innate immune dysfunction in Down syndrome
|
Tamim H. Shaikh, PhD
Autism & Down syndrome
Research genetic modifiers of autism spectrum disorders in patients with Down syndrome
|
Jingshi Shen, PhD
Immune system dysregulation in Down syndrome
Does trisomy 21 cause dysregulation of cytotoxic lymphocyte-mediated cell killing?
|
Richard Spritz, MD
Autoimmune disorders & Down syndrome
Analyze genetics of autoimmunity in Down syndrome — thyroid disease, celiac disease, type 1 diabetes and rheumatoid arthritis
|
Jerry Stitzel, PhD
Cognition & Down syndrome
Study gene expression changes specifically in a key group of neurons to improve our understanding of the molecular pathology of neuron loss in Down syndrome
|
Kelly Sullivan, PhD
Interferon Activity & Down syndrome
Defining the impact of modulating Interferon activity on cells from individuals with trisomy 21.
|
Ding Xue, PhD
Alzheimer’s disease & Down syndrome
Study the roles of presenilin and ubiquilin in developing treatments for Alzheimer’s disease in patients with Down syndrome
|
Michael Yeager, PhD
Autoimmune disorders & Down syndrome
Understand immune system disturbances in individuals with Down syndrome and drive development of newer therapies
|
Rui Yi, PhD
Genetic understanding of Down syndrome
Determine the effect of gene dosage imbalance on activity in trisomic embryonic stem cells
|
|